Paz-Pines demands regulation of doctor-drug company relationships

Move comes in wake of bribery arrest of senior TA oncologist.

By
May 18, 2006 01:35
1 minute read.
Paz-Pines demands regulation of doctor-drug company relationships

paz pines 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Minister-without-Portfolio Ophir Paz-Pines, who has been assigned responsibility for science and technology in the new government - as well as culture and sport - has called on Health Minister Ya'acov Ben-Yizri to set up a special committee to draft rules governing the relationship between physicians and pharmaceutical companies. Paz-Pines, who was speaking to a conference organized by the Movement for Quality Government on the "Struggle for Ethics," was referring to the arrest Tuesday of Dr. Arye Figer, a senior oncologist at Tel Aviv's Sourasky Medical Center, on suspicion of taking bribes in exchange for referring cancer patients to clinical trials run by pharmaceutical companies with which he allegedly had connections. Paz-Pines said it was "forbidden for there to be a direct connection between a physician and a drug company. This must be illegal. The public must know how decisions are made, and there is nothing like transparency." Paz-Pines said that when he was a backbencher, he had asked the Health Ministry to advocate bills on the issue, but "it was like talking to a wall. I am disturbed by the system of impossible pressures placed by vested interests with billions of shekels at stake on members of the committee that recommends expansion of the basket of health services. "As minister of science, I will do my best so that we don't have embarrassing situations, screaming headlines and human tragedies such as what we have seen in the Figer affair." The Israel Medical Association has a constitution that sets restrictions on the doctor-drug company relationship, but it is not legally binding.

Related Content

Jisr az-Zarq
April 3, 2014
Residents of Jisr az-Zarqa beckon Israel Trail hikers to enjoy their town

By SHARON UDASIN